Ilona Lorincz

Senior Fellow

Ilona Lorincz, MD

  • Associate Professor of Clinical Medicine and Director of Quality, Endocrinology, Diabetes, and Metabolism, Perelman School of Medicine

Ilona Lorincz, MD, MSHP is an Associate Professor of Clinical Medicine, and the Director of Quality for the Division of Endocrinology, Diabetes, and Metabolism at the Hospital of the University of Pennsylvania. She completed her undergraduate training at Dartmouth College, where she earned a degree in Psychology and the Brain Sciences and Neuroscience. She received her MD from Georgetown University School of Medicine. She did her internal medicine residency at the Hospital of the University of Pennsylvania and was a member of the Healthcare Leadership in Quality Track. During her endocrine fellowship, she completed an additional fellowship in QI/patient safety through the Penn Center for Health Care Improvement and Patient Safety (CHIPS) and obtained a Master’s in Health Policy Research.

Dr. Lorincz’s research focuses on improving health care delivery for patients with diabetes. She has a particular interest in optimizing primary care-diabetologist collaboration in the management of Type 2 diabetes, patient-physician communication, the use of technology to promote diabetes self-care behaviors, and improving the quality of health care delivery through examining psychosocial barriers. She also leads QI initiatives for Rodebaugh Diabetes Center. She is the Penn site PI for the Type 1 Diabetes Exchange Quality Improvement Collaborative (T1DX-QI), a national collaborative of 17 leading diabetes centers that seeks to improve the care of people with T1D by sharing QI tools and expertise across clinic sites and comparing real-world data from the clinics’ T1D populations. She is also the Penn site PI for a regional QI collaborative Knowing Diabetes By Heart, a joint venture from the American Diabetes Association (ADA) and American Heart Association. The goal of the collaborative is to share health system and public health best practices across diabetes, primary care, cardiology, industry, and public health stakeholders to reduce the burden of cardiovascular disease in diabetes. 

Dr. Lorincz also leads quality improvement, medication safety, and EHR optimization initiatives for hospitalized patients with diabetes for the University of Pennsylvania Health System.

Related Content